PBYI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Puma Biotechnology Inc (PBYI).


$149.72M Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

PBYI Market Cap. (MRY)


PBYI Shares Outstanding (MRY)


PBYI Assets (MRY)


Total Assets

$213.33M

Total Liabilities

$121.21M

Total Investments

$33.84M

PBYI Income (MRY)


Revenue

$230.47M

Net Income

$30.28M

Operating Expense

$135.10M

PBYI Cash Flow (MRY)


CF Operations

$38.92M

CF Investing

-$20.44M

CF Financing

-$33.85M

PBYI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

-

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

PBYI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$213,333,000 (-7.46%)

$230,528,000 (3.81%)

$222,059,000 (-2.00%)

$226,585,000 (-7.22%)

Assets Current

$147,658,000 (-5.46%)

$156,185,000 (16.31%)

$134,281,000 (-4.10%)

$140,022,000 (-4.19%)

Assets Non-Current

$65,675,000 (-11.66%)

$74,343,000 (-15.31%)

$87,778,000 (1.40%)

$86,563,000 (-11.74%)

Goodwill & Intangible Assets

$51,131,000 (-16.00%)

$60,871,000 (-13.79%)

$70,610,000 (6.78%)

$66,125,000 (-10.81%)

Shareholders Equity

$92,125,000 (72.38%)

$53,442,000 (147.33%)

$21,608,000 (983.40%)

-$2,446,000 (58.90%)

Property Plant & Equipment Net

$5,094,000 (-41.09%)

$8,647,000 (-30.87%)

$12,508,000 (-20.70%)

$15,773,000 (-16.48%)

Cash & Equivalents

$69,219,000 (-18.17%)

$84,585,000 (11.00%)

$76,201,000 (5.86%)

$71,981,000 (-23.54%)

Accumulated Other Comprehensive Income

$6,000 (250.00%)

-$4,000 (0%)

$0 (0%)

-$2,000 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$33,837,000 (151.67%)

$13,445,000 (80.13%)

$7,464,000 (-66.51%)

$22,286,000 (95.37%)

Investments Current

$31,746,000 (179.60%)

$11,354,000 (133.00%)

$4,873,000 (-74.32%)

$18,975,000 (134.38%)

Investments Non-Current

$2,091,000 (0.00%)

$2,091,000 (-19.30%)

$2,591,000 (-21.75%)

$3,311,000 (0.00%)

Inventory

$8,724,000 (23.22%)

$7,080,000 (56.43%)

$4,526,000 (-36.33%)

$7,109,000 (105.82%)

Trade & Non-Trade Receivables

$32,011,000 (-33.08%)

$47,837,000 (18.56%)

$40,350,000 (24.05%)

$32,526,000 (27.34%)

Trade & Non-Trade Payables

$5,509,000 (-20.03%)

$6,889,000 (6.97%)

$6,440,000 (-42.37%)

$11,174,000 (-7.47%)

Accumulated Retained Earnings (Deficit)

-$1,314,886,000 (2.25%)

-$1,345,164,000 (1.58%)

-$1,366,755,000 (0.00%)

-$1,366,757,000 (-2.18%)

Tax Assets

$7,075,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$74,082,000 (-33.55%)

$111,490,000 (-2.44%)

$114,281,000 (-2.02%)

$116,641,000 (-3.57%)

Debt Current

$50,869,000 (31.12%)

$38,797,000 (837.13%)

$4,140,000 (15.84%)

$3,574,000 (-79.44%)

Debt Non-Current

$23,213,000 (-68.07%)

$72,693,000 (-34.00%)

$110,141,000 (-2.59%)

$113,067,000 (9.17%)

Total Liabilities

$121,208,000 (-31.55%)

$177,086,000 (-11.66%)

$200,451,000 (-12.48%)

$229,031,000 (-8.45%)

Liabilities Current

$96,111,000 (-3.29%)

$99,382,000 (28.26%)

$77,484,000 (-29.29%)

$109,586,000 (-4.09%)

Liabilities Non-Current

$25,097,000 (-67.70%)

$77,704,000 (-36.81%)

$122,967,000 (2.95%)

$119,445,000 (-12.12%)

PBYI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$230,468,000 (-2.19%)

$235,637,000 (3.34%)

$228,031,000 (-9.92%)

$253,155,000 (12.46%)

Cost of Revenue

$64,404,000 (2.75%)

$62,682,000 (13.77%)

$55,093,000 (-13.51%)

$63,701,000 (61.78%)

Selling General & Administrative Expense

$80,163,000 (-10.86%)

$89,933,000 (-0.05%)

$89,978,000 (-22.63%)

$116,294,000 (-1.85%)

Research & Development Expense

$54,935,000 (9.04%)

$50,382,000 (-3.56%)

$52,240,000 (-27.31%)

$71,870,000 (-26.40%)

Operating Expenses

$135,098,000 (-3.72%)

$140,315,000 (-5.97%)

$149,218,000 (-20.70%)

$188,164,000 (-12.94%)

Interest Expense

$12,452,000 (-6.59%)

$13,330,000 (14.99%)

$11,592,000 (-9.49%)

$12,807,000 (-8.82%)

Income Tax Expense

-$6,178,000 (-670.45%)

$1,083,000 (138.02%)

$455,000 (40.43%)

$324,000 (56.52%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$30,278,000 (40.23%)

$21,591,000 (1079450.00%)

$2,000 (100.01%)

-$29,126,000 (51.45%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

$30,278,000 (40.23%)

$21,591,000 (1079450.00%)

$2,000 (100.01%)

-$29,126,000 (51.45%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$30,278,000 (40.23%)

$21,591,000 (1079450.00%)

$2,000 (100.01%)

-$29,126,000 (51.45%)

Weighted Average Shares

$48,648,701 (3.21%)

$47,134,331 (5.51%)

$44,674,501 (9.93%)

$40,638,852 (2.69%)

Weighted Average Shares Diluted

$49,100,433 (3.26%)

$47,550,852 (5.83%)

$44,929,998 (10.56%)

$40,638,852 (2.69%)

Earning Before Interest & Taxes (EBIT)

$36,552,000 (1.52%)

$36,004,000 (198.81%)

$12,049,000 (175.33%)

-$15,995,000 (65.03%)

Gross Profit

$166,064,000 (-3.98%)

$172,955,000 (0.01%)

$172,938,000 (-8.72%)

$189,454,000 (2.00%)

Operating Income

$30,966,000 (-5.13%)

$32,640,000 (37.61%)

$23,720,000 (1738.76%)

$1,290,000 (104.24%)

PBYI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$20,438,000 (-6.87%)

-$19,125,000 (-369.21%)

$7,104,000 (165.29%)

-$10,881,000 (-132.57%)

Net Cash Flow from Financing

-$33,846,000 (0%)

$0 (0%)

$12,223,000 (138.28%)

-$31,931,000 (-221.50%)

Net Cash Flow from Operations

$38,918,000 (44.09%)

$27,009,000 (270.65%)

-$15,827,000 (-176.64%)

$20,650,000 (2571.41%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$15,366,000 (-294.90%)

$7,884,000 (125.26%)

$3,500,000 (115.79%)

-$22,162,000 (-191.41%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$20,382,000 (-214.29%)

-$6,485,000 (-145.98%)

$14,104,000 (229.62%)

-$10,881,000 (-125.04%)

Capital Expenditure

-$56,000 (60.00%)

-$140,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$33,330,000 (0%)

$0 (0%)

$0 (0%)

-$11,931,000 (0%)

Issuance (Purchase) of Equity Shares

$150,000 (0%)

$0 (0%)

$12,223,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,245,000 (-19.54%)

$10,247,000 (-13.35%)

$11,826,000 (-63.76%)

$32,633,000 (-10.78%)

Depreciation Amortization & Accretion

$11,524,000 (0.04%)

$11,519,000 (29.14%)

$8,920,000 (-15.83%)

$10,598,000 (5.63%)

PBYI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

72.10% (-1.77%)

73.40% (-3.17%)

75.80% (1.34%)

74.80% (-9.33%)

Profit Margin

13.10% (42.39%)

9.20% (0%)

0% (0%)

-11.50% (56.93%)

EBITDA Margin

20.90% (3.47%)

20.20% (119.57%)

9.20% (538.10%)

-2.10% (86.79%)

Return on Average Equity (ROAE)

46.10% (-20.79%)

58.20% (0%)

0% (0%)

-358.10% (60.64%)

Return on Average Assets (ROAA)

14.20% (36.54%)

10.40% (0%)

0% (0%)

-12.00% (50.21%)

Return on Sales (ROS)

15.90% (3.92%)

15.30% (188.68%)

5.30% (184.13%)

-6.30% (68.97%)

Return on Invested Capital (ROIC)

46.50% (48.56%)

31.30% (209.90%)

10.10% (150.50%)

-20.00% (55.46%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

4.92 (-47.74%)

9.41

-

-4.22 (37.45%)

Price to Sales Ratio (P/S)

0.64 (-25.64%)

0.87 (4.46%)

0.83 (69.88%)

0.49 (-72.95%)

Price to Book Ratio (P/B)

1.63 (-57.84%)

3.85 (-56.87%)

8.94 (117.58%)

-50.81 (25.88%)

Debt to Equity Ratio (D/E)

1.32 (-60.29%)

3.31 (-64.28%)

9.28 (109.91%)

-93.64 (-122.74%)

Earnings Per Share (EPS)

0.62 (34.78%)

0.46 (0%)

0 (0%)

-0.72 (52.63%)

Sales Per Share (SPS)

4.74 (-5.24%)

5 (-2.06%)

5.1 (-18.06%)

6.23 (9.51%)

Free Cash Flow Per Share (FCFPS)

0.8 (40.18%)

0.57 (261.02%)

-0.35 (-169.69%)

0.51 (2722.22%)

Book Value Per Share (BVPS)

1.89 (67.02%)

1.13 (134.30%)

0.48 (906.67%)

-0.06 (60.00%)

Tangible Assets Book Value Per Share (TABVPS)

3.33 (-7.36%)

3.6 (6.17%)

3.39 (-14.13%)

3.95 (-8.14%)

Enterprise Value Over EBIT (EV/EBIT)

5 (-28.57%)

7 (-63.16%)

19 (272.73%)

-11 (-22.22%)

Enterprise Value Over EBITDA (EV/EBITDA)

3.51 (-29.41%)

4.97 (-54.64%)

10.97 (135.10%)

-31.25 (-159.65%)

Asset Turnover

1.08 (-4.76%)

1.13 (1.34%)

1.12 (7.39%)

1.04 (15.14%)

Current Ratio

1.54 (-2.29%)

1.57 (-9.29%)

1.73 (35.60%)

1.28 (-0.08%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$38,862,000 (44.64%)

$26,869,000 (269.77%)

-$15,827,000 (-176.64%)

$20,650,000 (2740.44%)

Enterprise Value (EV)

$168,824,436 (-28.59%)

$236,405,868 (2.78%)

$230,002,771 (36.37%)

$168,662,361 (-60.76%)

Earnings Before Tax (EBT)

$24,100,000 (6.29%)

$22,674,000 (4861.49%)

$457,000 (101.59%)

-$28,802,000 (51.83%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$48,076,000 (1.16%)

$47,523,000 (126.63%)

$20,969,000 (488.53%)

-$5,397,000 (84.89%)

Invested Capital

$70,954,000 (-26.99%)

$97,180,000 (-13.27%)

$112,045,000 (17.28%)

$95,534,000 (15.61%)

Working Capital

$51,547,000 (-9.25%)

$56,803,000 (0.01%)

$56,797,000 (86.61%)

$30,436,000 (-4.54%)

Tangible Asset Value

$162,202,000 (-4.39%)

$169,657,000 (12.02%)

$151,449,000 (-5.62%)

$160,460,000 (-5.66%)

Market Capitalization

$149,717,436 (-27.32%)

$205,983,868 (6.70%)

$193,057,771 (55.33%)

$124,292,361 (-69.53%)

Average Equity

$65,676,000 (76.99%)

$37,107,500 (110.10%)

$17,661,500 (117.12%)

$8,134,500 (23.36%)

Average Assets

$213,301,250 (2.69%)

$207,721,000 (1.93%)

$203,791,250 (-16.09%)

$242,882,250 (-2.38%)

Invested Capital Average

$78,617,000 (-31.65%)

$115,018,000 (-3.96%)

$119,765,000 (50.13%)

$79,776,750 (-21.71%)

Shares

49,087,684 (3.19%)

47,571,332 (4.23%)

45,640,135 (11.63%)

40,885,645 (2.82%)